Proteomics & Protein Research
News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
Sera Prognostics Prices $50M Stock Offering
The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.
The firm's Protein Sciences segment saw revenues increase 7 percent, while the Diagnostics and Spatial Biology segment's revenues rose 12 percent.
The firm is developing a protein-based lung cancer screening test that also utilizes machine learning.
Proteomics International Planning Australia Launch of Endometriosis Test in Q2; US Launch to Follow
Premium
The proteomic blood test could be a noninvasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose.
Sapient Partnering With Alamar Bio to Offer Proteomics Services on NULISA Platform
Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.